Aya A Mohammed
Role not yet determined Is this you? Add your title
Also affiliated: University of Technology - Iraq (2021–2022)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Aya A Mohammed's research focuses on disease mechanisms, particularly investigating the role of myeloid cells in ischemic retinopathies and how histone deacetylase 3 (HDAC3) mediates retinal endothelial cell metabolic reprogramming and angiogenesis. Mohammed's work has been published in peer-reviewed journals, with recent publications exploring these topics alongside investigations into the properties of nano-reinforced rubber composites and the protective effects of vitamin C and zinc against tissue damage from Toxoplasma gondii infection.
Mohammed is affiliated with the University of Arkansas for Medical Sciences and has collaborated with researchers including Esraa Shosha, Abdelrahman Y. Fouda, Nancy J. Rusch, and Christian D. Mitchell. With an h-index of 2 and 60 total citations across 4 publications, Mohammed's scholarly contributions are ongoing.
Metrics
- h-index: 2
- Publications: 4
- Citations: 60
Selected Publications
-
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis (2025)
-
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions (2024)
Collaboration Network
Top Collaborators
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Similar Researchers
Based on overlapping research topics